Cardiopulmonary bypass reduces peripheral microvascular contractile function by inhibition of mitogen-activated protein kinase activity. [electronic resource]
Producer: 20031016Description: 247-54 p. digitalISSN:- 0039-6060
- Aged
- Arterioles -- enzymology
- Cardiopulmonary Bypass -- adverse effects
- Cell Cycle Proteins
- Dual Specificity Phosphatase 1
- Enzyme Inhibitors -- pharmacology
- Female
- Flavonoids -- pharmacology
- Humans
- Imidazoles -- pharmacology
- Immediate-Early Proteins -- metabolism
- Male
- Microcirculation -- drug effects
- Middle Aged
- Mitogen-Activated Protein Kinase 1 -- antagonists & inhibitors
- Mitogen-Activated Protein Kinase 3
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Muscle, Skeletal -- blood supply
- Phosphoprotein Phosphatases
- Protein Phosphatase 1
- Protein Tyrosine Phosphatases -- metabolism
- Pyridines -- pharmacology
- Tissue Distribution
- Vasoconstriction -- drug effects
- p38 Mitogen-Activated Protein Kinases
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.